Filing Details

Accession Number:
0001104659-20-126458
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-17 18:11:27
Reporting Period:
2020-11-13
Accepted Time:
2020-11-17 18:11:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727510 Enzon Pharmaceuticals Inc. ENZN Biological Products, (No Disgnostic Substances) (2836) 222372868
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821517 Jordan Bleznick C/O Enzon Pharmaceuticals, Inc.
20 Commerce Drive (Suite 135)
Cranford NJ 07016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-13 100,000 $0.15 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price of multiple transactions, with shares purchased at prices ranging from $0.1526 to $0.155 per share. The reporting person hereby undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the issuer or a stockholder of the issuer, full information regarding the number of shares purchased at each separate price.